1.
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
2.
3.
4.
5.
6.
7.
8.
9.
Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE).
Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea.